Activity-Based Intervention to Address Cannabis Use

N/ANot Yet RecruitingNCT07813442

University of Michigan300 enrolled

Overview

This study is being completed to test a method to promote patient-centered outcomes among people who use cannabis behaviors.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

300

Conditions

Cannabis Use

Interventions

Motivational and Behavioral Economics Informed InterventionBEHAVIORAL

6 session telemedicine-delivered intervention with coaching sessions and small incentives for activity engagement.

Enhanced Usual CareBEHAVIORAL

Brief psychoeducation and referral resources

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * current cannabis use disorder * active cannabis use, * camera/technology/phone access * able to give informed consent. Exclusion Criteria: * inability to speak English * conditions precluding informed consent, full participation, or understanding of interventions/assessments * past 90-day cannabis use disorder/substance use disorder treatment * current cancer treatment * medical cannabis certification for current cancer, end-of-life care, or progressive debilitating disease * active moderate/severe other substance use disorder(s) or injection drug use

Locations (1)

University of Michigan, Ann Arbor, Michigan 48109

Ann Arbor, Michigan, United States

Outcomes

Primary Outcomes

Cannabis use

Change in frequency of cannabis use measured by the Timeline Follow Back

Time frame: 3-, 6-, 12-months

Secondary Outcomes

Cannabis use disorder symptoms

Change in cannabis use disorder symptoms measured by the Diagnostic \& Statistical Manual-5 checklist where higher scores indicate a worse outcome (0 min score, 11 max score)

Time frame: 3-, 6-, 12-months

Depressive symptoms

Change in depression symptom severity as measured by Patient Health Questionnaire-where higher scores indicate a worse outcome (min score = 0, max score = 24)

Time frame: 3-, 6-, 12-months

Anxiety symptoms

Change in anxiety symptom severity as measured by Generalized Anxiety Disorder-7 questionnaire where higher scores indicate a worse outcome (min score = 0, max score = 21)

Time frame: 3-, 6-, 12-months

Central Contacts

Braden Kilpatrick

CONTACT

(734) 623-0713 bkilpatr@med.umich.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.